CENTANY Drug Patent Profile
✉ Email this page to a colleague
When do Centany patents expire, and when can generic versions of Centany launch?
Centany is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Centany
A generic version of CENTANY was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CENTANY?
- What are the global sales for CENTANY?
- What is Average Wholesale Price for CENTANY?
Summary for CENTANY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 2 |
Patent Applications: | 5,308 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CENTANY? | CENTANY excipients list |
DailyMed Link: | CENTANY at DailyMed |
![CENTANY drug patent expirations Drug patent expirations by year for CENTANY](/p/graph/s/t/CENTANY-patent-expirations.png)
Recent Clinical Trials for CENTANY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Washington | Phase 2 |
St. Louis Children's Hospital | Phase 2 |
Cook Children's Medical Center | Phase 2 |
US Patents and Regulatory Information for CENTANY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | BX | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CENTANY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CENTANY
See the table below for patents covering CENTANY around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2165723 | ⤷ Sign Up | |
European Patent Office | 0933081 | Compositions pharmaceutiques contenant mupirocine (Pharmaceutical compositions containing mupirocin) | ⤷ Sign Up |
Canada | 2259764 | COMPOSITIONS PHARMACEUTIQUES RENFERMANT DE LA MUPIROCINE (PHARMACEUTICAL COMPOSITIONS CONTAINING MUPIROCIN) | ⤷ Sign Up |
Germany | 69900561 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |